✦ LIBER ✦

Pinacidil, a new vasodilator, in the treatment of patients with moderate to severe hypertension

✍ Scribed by K. Koliopoulos; D. E. Papadoyannis; N. B. Karatzas

Publisher: Springer
Year: 1984
Tongue: English
Weight: 280 KB
Volume: 27
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00542161

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pinacidil, a new vasodilator, in the tre

Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension

✍ V. D'Arcy; M. Laher; D. McCoy; P. Sullivan; C. H. Walsh; M. P. Hickey 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 328 KB

Treatment of essential hypertension and

Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: A new vasodilator

✍ E. G. Breen; D. Mulhall; J. A. B. Keogh 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 775 KB

Comparative evaluation of the new vasodi

Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension

✍ M. G. Bianchetti; P. Weidmann; K. Boehringer; L. Link; H. Schiffl; C. Beretta-Pi 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 852 KB

Chronic treatment with the new potent va

Chronic treatment with the new potent vasodilator Ro 12-4713 in moderate to severe hypertension: Effects on blood pressure, endocrine function, sodium and plasma volume

✍ M. Grimm; P. Weidmann; A. Meier; H. Schiffl; W. H. Ziegler 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 811 KB

Evaluation of celiprolol, a new cardiose

Evaluation of celiprolol, a new cardioselective beta1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly

✍ K. D. Lamon 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 499 KB

Celiprolol hydrochloride is a cardioselective beta 1-adrenergic antagonist with partial agonist activity. The studies discussed were designed to assess celiprolol's pharmacokinetic disposition, its efficacy versus placebo and other beta blockers, its relative safety profile, and its therapeutic rati

Successful adult-to-adult living donor l

Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension

✍ Hideaki Uchiyama; Yuji Soejima; Akinobu Taketomi; Tomoharu Yoshizumi; Noboru Har 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Portopulmonary hypertension (PPHTN) is one of the most devastating consequences of end-stage liver cirrhosis. When a patient has moderate to severe PPHTN, his or her candidature for liver transplantation is denied. Here we report a successful adult-to-adult living donor liver transplantation (LDLT)